Bioelectronics, the implantation of electrically active devices in the human body, is growing rapidly. However, the metals used for such implants degrade rapidly in the body; can measure only electrical activity, not biochemical; are incompatible with MRI; and can cause toxic byproducts during stimulation. Grapheton is using patented carbon materials to overcome and improve the capabilities of bioelectronic implants.
